Problem pathogens: Prevention of malaria in travellers

Lancet Infectious Diseases

Volumn 6, Issue 3, 2006, Pages 139-149

  Franco Paredes, Carlos ^a,b,c   Santos Preciado, José Ignacio ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISIN; ATOVAQUONE PLUS PROGUANIL; BENFLUMETOL; CHLOROQUINE; DOXYCYCLINE; FANSIDAR; HALOFANTRINE; INSECT REPELLENT; MALOPRIM; MEFLOQUINE; METOCLOPRAMIDE; N,N DIETHYL 3 METHYLBENZAMIDE; PERMETHRIN; PICARDIN; PIPERIDINE DERIVATIVE; PRIMAQUINE; PROGUANIL; QUININE; RIFAMPICIN; SUNSCREEN; TETRACYCLINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; AGRANULOCYTOSIS; BED NET; BONE MARROW TOXICITY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE TRANSMISSION; DIZZINESS; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG TOLERABILITY; DYSPHORIA; EPIDEMIOLOGICAL DATA; ESOPHAGITIS; ESOPHAGUS ULCER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HEMOLYSIS; HEPATITIS; HUMAN; INFECTION PREVENTION; INFECTION RISK; MALARIA; MALARIA CONTROL; NAUSEA; NIGHTMARE; PARASITE TRANSMISSION; PARASITE VIRULENCE; PATIENT COMPLIANCE; PHOTOSENSITIVITY; PLASMODIUM FALCIPARUM; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PROTECTIVE CLOTHING; PSORIASIS; QT PROLONGATION; REVIEW; RISK BENEFIT ANALYSIS; SELF MEDICATION; SIDE EFFECT; SPONTANEOUS ABORTION; STEVENS JOHNSON SYNDROME; STILLBIRTH; TINNITUS; TOURISM; TOXIC EPIDERMAL NECROLYSIS; TRAVEL; VAGINITIS; VOMITING;

ANIMALS; ANOPHELES; ANTIMALARIALS; DRUG RESISTANCE; HUMANS; INSECT BITES AND STINGS; MALARIA; PLASMODIUM; RISK FACTORS; TRAVEL;

EID: 33144490271     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(06)70410-8     Document Type: Review

References (99)

1. NJ White The treatment of malaria N Engl J Med 335 1996 800 806
2. LH Chen, JS Keystone New strategies for the prevention of malaria in travelers Infect Dis Clin N Am 9 2005 185 210
3. P Schlagenhauf Malaria: from prehistory to present Infect Dis Clin N Am 18 2004 189 205
4. BM Greenwood, K Bojang, CJ Whitty, GA Targett Malaria Lancet 365 2005 1487 1498
5. KN Suh, KC Kain, JS Keystone Malaria Can Med Assoc J 170 2004 1693 1702
6. AA Escalante, OE Cornejo, DE Freeland A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite Proc Natl Acad Sci USA 102 2005 1980 1985
7. LJ Bruce-Chwatt Paleogenesis and paleo-epidemiology of primate malaria Bull World Health Organ 2 1965 363 387
8. AA Escalante, FJ Ayala Phylogeny of the malarial genus plasmodium derived from the rRNA sequences Proc Natl Acad Sci USA 91 1994 11373 11377
9. J Sachs, P Malaney The economic and social burden of malaria Nature 415 2002 680 685
10. RW Snow, CA Guerra, AM Noor, HY Myint, SI Hay The global distribution of clinical episodes of Plasmodium falciparum malaria Nature 434 2005 214 217
11. NJ White Antimalarial drug resistance J Clin Invest 113 2004 1084 1092
12. LH Miller, DI Baruch, K Marsh, OK Doumbo The pathogenic basis of malaria Nature 414 2002 673 679
13. KI Barnes, NJ White Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum Acta Trop 94 2005 230 240
14. L Rombo Who needs drug prophylaxis against malaria? My personal view J Travel Med 12 2005 217 221
15. GD Shanks, KC Kain, JS Keystone Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future Clin Infect Dis 33 2001 381 385
16. AE Greenberg, HO Lobel Mortality from Plasmodium falciparum malaria in travelers from the United States, 1959 to 1987 Ann Intern Med 113 1999 326 327
17. Centers for Disease Control and Prevention Malaria surveillance - United States, 2003 Morb Mortal Wkly Rep MMWR 54 2005 25 39
18. D de Savigny, F Binka Monitoring future impact on malaria burden in sub-Saharan Africa Am J Trop Med Hyg 71 suppl 2 2004 224 231
19. E Petersen Malaria chemoprophylaxis: when should we use it and what are the options? Expert Rev Anti-infect Ther 2 2004 119 132
20. TE Wellems, LH Miller Two worlds of malaria N Engl J Med 349 2003 1496 1498
21. RD Newman, ME Parise, AM Barber, RW Steketee Malaria-related deaths among U.S. travelers, 1963-2001 Ann Intern Med 141 2004 547 555
22. HH Askling, J Nilsson, A Tegnelli, R Janzon, K Ekdahl Malaria risk in travelers Emerg Infect Dis 11 2005 436 441
23. DR Hill, RH Behrens, DH Bradley The risk of malaria in travelers to Thailand Trans R Soc Trop Med Hyg 90 1996 680 681
24. T Jelinek, C Schulte, R Behrens Imported falciparum malaria in Europe: sentinel surveillance data from the European Network on Surveillance of Imported Infectious Diseases Clin Infect Dis 34 2002 572 576
25. World Tourism Organization UNWTO news 4th quarter 2005. World Tourism Organization http://www.world-tourism.org/newsroom/magazine/archives/news4_05_e. pdf 2003 (accessed Feb 1, 2006)
26. AJ Reid, CJ Whitty, HM Ayles Malaria at Christmas: risks of prophylaxis versus risks of malaria BMJ 317 1998 1506 1508
27. DJ Bradley, DC Warhurst, MA Blaze Malaria imported into the United Kingdom in 1996 Eurosurveillance 3 1998 40 42
28. Department of Economic and Social Affairs, United Nations International migration report 2002 http://www.un.org/esa/population/publications/ittmig2002/ 2002ITTMIGTEXT22-11.pdf (accessed Jan 13, 2006)
29. A Vicas, H Albrecht, JL Lennox, C del Rio Imported malaria at an inner-city hospital in the United States Am J Med Sci 329 2005 6 12
30. K Leder, J Black, D O'Brien Malaria in travelers: a review of the GeoSentinel surveillance network Clin Infect Dis 39 2004 1104 1112
31. N Bacaner, B Stauffer, DR Boulware, PF Walker, JS Keystone Travel medicine considerations for North American immigrants visiting friends and relatives JAMA 291 2004 2856 2864
32. SY Angell, MS Cetron Health disparities among travelers visiting friends and relatives abroad Ann Intern Med 142 2005 67 73
33. M Fulford, JS Keystone Health risks associated with visiting friends and relatives in developing countries Curr Infect Dis Rep 7 2005 48 53
34. L Leonard, M Van Landingham Adherence to travel health guidelines: the experience of Nigerian immigrants in Houston, Texas J Immigrant Health 3 2001 31 45
35. JK Baird Effectiveness of antimalarial drugs N Engl J Med 325 2005 1565 1574
36. SC Kain, GD Shanks, JS Keystone Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens Clin Infect Dis 33 2001 226 234
37. ET Ryan, KC Kain Health advice and immunizations for travelers N Engl J Med 342 2000 1716 1725
38. HO Lobel, MA Baker, FA Gras Use of malaria prevention measures by North American and European travelers to east Africa J Travel Med 8 2001 167 172
39. CC dos Santos, A Anvar, JS Keystone, KC Kain Survey of use of malaria prevention by Canadian visiting India CMAJ 160 1999 195 200
40. MS Fradin, JF Day Comparative efficacy of insect repellents against mosquito bites N Engl J Med 347 2002 13 18
41. Anon Insect repellents The Medical Letter on Drugs and Therapeutics 43 2003 41 42
42. RJ Pollack, AE Kiszewksi, A Spielman Repelling mosquitoes N Engl J Med 347 2002 2 3
43. Centers for Disease Control and Prevention Traveler's health http://www.cdc.gov/travel (accessed Jan 13, 2006)
44. Health Canada Canadian recommendations for the prevention and treatment of malaria among international travellers 1997 http://www.phac-aspc.gc.ca/ publicat/ccdr-rmtc/97vol23/23s5/ (accessed Jan 13, 2006)
45. NJ White Plasmodium species (malaria) Yu V Weber R White NJ Antimicrobial therapy and vaccines 2nd edit. 2003 Apple Trees Productions New York, NY 1609 1634
46. KC Kain Prophylactic drugs for malaria: why do we need another one? J Travel Med 6 suppl 1 1999 S2 S7
47. World Tourism Organization WTO world tourism barometer http://www.world-tourism.org/facts/menu.html (accessed Feb 1, 2006)
48. World Tourism Organization Facts and figures http://www.world-tourism. org/market_research/facts/menu.html (accessed Feb 1, 2006)
49. JH Elliot, D O'Brien, K Leder Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers J Travel Med 11 2004 213 217
50. E Schwartz, M Parise, P Kozarsky, M Cetron Delayed onset of malaria-impliations for chemoprophylaxis in travelers N Engl J Med 349 2003 1510 1516
51. WHO Malaria. Stand-by emergency treatment http://whqlibdoc.who.int/ publications/2005/9241580364_chap7.pdf (accessed Feb 1, 2006)
52. KC Kain, DW MacPherson, T Kelton Malaria deaths in visitors to Canada and in Canadian travelers: a case series CMAJ 164 2001 654 659
53. K Kofoed, E Petersen The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark J Travel Med 10 2003 150 154
54. HH Askling, K Ekdhahl, R Janzon Travellers returning to Sweden with falciparum malaria: pre-travel advice, behaviour, chemoprophylaxis and diagnostic delay Scand J Infect Dis 37 2005 760 765
55. G Dorsey, Gandhi, JH Oyugi Difficulties in the prevention, diagnosis, and treatment of imported malaria Arch Intern Med 50 2000 597 599
56. NJ White Antimalarial drug resistance: the pace quickens J Antimicrob Chemother 30 1992 571 585
57. RQ Taylor, NJ White Antimalarial drug toxicity. A review Drug Saf 27 2004 25 61
58. P Schlagenhauf, R Steffen, A Tschopp Behavioural aspects of travellers in their use of malaria presumptive treatment Bull World Health Organ 73 1995 215 221
59. Centers for Disease Control and Prevention Health information for international travel 2003-2004 2004 CDC Atlanta, GA 99 115
60. FE de Alencar, C Cerutti Jr, RR Durlacher Atovaquone and proguanil for the treatment of malaria in Brazil J Infect Dis 175 1997 1544 1547
61. P Schlagenhauf, A Tschopp, R Johnson Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomized, double blind, four arm study BMJ 327 2003 1078
62. R McGready, EA Ashley, E Moo A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy J Infect Dis 192 2005 846 853
63. F Nosten, F ter Kuile, T Chongsuphajaisiddhi Mefloquine resistant falciparum malaria on the Thai Burmese border Lancet 337 1991 1140 1143
64. F Nosten, FO ter Kuile, C Luxemburger Treatment of multidrug resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination J Infect Dis 170 1994 971 977
65. F Nosten, M Van Vugt, R Price Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study Lancet 356 2000 297 302
66. L Suebsaeng, WH Wernsdorfer, W Rooney Sensitivity to quinine and mefloquine of Plasmodium falciparum in Thailand Bull World Health Organ 64 1986 759 765
67. A Brockman, RN Price, M van Vugt Plasmodium falciparum antimalarial drug susceptibility on the northwestern border of Thailand during five years of extensive artesuante-mefloquine use Trans R Soc Trop Med Hyg 94 2000 537 544
68. WH Wernsdorfer Epidemiology of drug resistance in malaria Acta Trop 56 1994 143 156
69. S Pukrittayakamee, W Supanaranond, S Looareesuwan Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand Trans R Soc Trop Med Hyg 88 1994 324 327
70. IW Sumawinata, B Leksana, A Sutamihardja Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua Am J Trop Med Hyg 68 2003 416 420
71. S Looareesuwan, JD Chulay, CJ Canfield, DB Hutchinson Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria Am J Trop Med Hyg 60 1999 533 541
72. JK Baird Resistance to chloroquine by Plasmodium vivax Antimicrob Agents Chemother 48 2004 4075 4083
73. H Stemberger, R Leimer, G Widermann Tolerability of long-term prophylaxis with Fansidar: a randomized double-blind study in Nigeria Acta Trop 41 1984 391 399
74. D Huzly, C Schonfeld, W Beurle Malaria chemoprophylaxis in German tourists: a prospective study on compliance and adverse reactions J Travel Med 3 1996 148 155
75. JC Wetsteyn, A de Geus Comparison of three regimens for malaria prophylaxis in travelers to east, central and Southern Africa BMJ 307 1993 1041 1043
76. Baudon D, Martet G, Pascal B, et al. Efficacy of daily antimalarial chemoprophylaxis in tropical Africa using either doxycycline or chloroquine-proguanil: a study conducted in 1996 in the French Army. Trans R Soc Trop Med Hyg 2999; 3: 148-155.
77. B Hogh, PD Clarke, D Camus Atovaquone-proguanil versus chlorquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study Lancet 356 2000 1888 1894
78. PJ Barret, PD Emmins, PD Clarke, DJ Bradley Comparison of adverse events associated with the use of mefloquine and combination of chloroquine and proguanil as anti-malarial prophylaxis: postal and telephone survey of travellers BMJ 313 1996 525 528
79. E Petersen, T Ronne, A Ronn, I Bygbjerg, SO Larsen Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers J Travel Med 7 2000 79 84
80. P Schlagenhauf Mefloquine for malaria chemoprophylaxis 1992-1998: a review J Travel Med 6 1999 122 133
81. HO Lobel, RA Gerber Malaria prevention for long-term travelers Schlagenhauf P Travelers' malaria 2001 BC Decker Hamilton, OH 261 269
82. S Looareesuwan, P Wilairatana, S Krudsood Chloroquine sensitivity of Plasmodium vivax in Thailand Ann Trop Med Parasitol 93 1999 225 230
83. GD Shanks, PG Kremsner, TY Sukwa Atovaquone and proguanil hydrochloride for prophylaxis of malaria J Travel Med 6 suppl 1 1999 S21 S27
84. GD Shanks, DM Gordon, FW Klotz Efficacy and safety of atovaquone-proguanil for suppressive prophylaxis against Plasmodium falciparum malaria Clin Infect Dis 27 1998 494 499
85. B Lell, D Luckner, M Djave Randomized placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children Lancet 351 1998 709 713
86. D Camus, F Djossou, J Schilthuis Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study Clin Infect Dis 38 2004 1716 1723
87. D Overbosch, H Schilthuis, U Bienzle Atovaquone-proguanil versus mefloquine for malaria prophylaxis in non-immune travelers: a randomized, double-blind study Clin Infect Dis 33 2001 1015 1021
88. HO Lobel, KW Bernard, SL Williams Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dose regimen JAMA 265 1991 361 364
89. E Schwartz, G Regev-Yochay Primaquine as prophylaxis for malaria for nonimmune travelers: a comparison with mefloquine and doxycycline Clin Inifect Dis 29 1999 1502 1506
90. J Soto, J Toledo, M Rodriguez Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial Ann Intern Med 129 1998 241 244
91. DL Wesche, BG Schuster, W Wen-Xiu, R Woosley Mechanisms of cardiotoxicity of halofantrine Clin Pharmacol Ther 67 2000 521 529
92. CS Hatton, TE Peto, C Bunch Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria Lancet 1 1986 411 414
93. P Schlagenhauf, R Steffen Stand-by treatment of malaria in travelers: a review J Trop Med Hyg 97 1994 151 160
94. HD Northdurft, T Jelinek, SM Pechel Stand-by treatment of suspected malaria in travelers Trop Med Parasitol 46 1995 161 163
95. P Newton, S Proux, M Green Fake artesunate in southeast Asia Lancet 357 2001 1948 1950
96. LM Causer, S Filler, M Wilson Evaluation of reported malaria chemoprophylactic failure among travelers in a US university exchange program, 2002 Clin Infect Dis 39 2004 1583 1588
97. C Franco-Paredes, R Dismukes, D Nicolls, P Kozarsky Neurotoxicity due to antimalarial therapy associated with misdiagnosis of malaria Clin Infect Dis 40 2005 1710 1711
98. B Lell, JF Faucher, MA Missinou Malaria chemoprophylaxis with tafenoquine: a randomized study Lancet 355 2000 2041 2045
99. DS Walsh, P Wilairatana, DB Tang Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria response Clin Infect Dis 39 2004 1095 1103